Down Syndrome, Obesity, Alzheimer’s Disease, and Cancer: A Brief Review and Hypothesis
Down syndrome (trisomy 21), a complex mix of physical, mental, and biochemical issues, includes an increased risk of Alzheimer’s disease and childhood leukemia, a decreased risk of other tumors, and a high frequency of overweight/obesity. Certain features related to the third copy of chromosome 21 (...
Main Author: | Daniel W. Nixon |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-03-01
|
Series: | Brain Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/2076-3425/8/4/53 |
Similar Items
-
The Role of Leptin and Adiponectin in Obesity-Associated Cognitive Decline and Alzheimer’s Disease
by: Leticia Forny-Germano, et al.
Published: (2019-01-01) -
Leptin, insulin and thyroid hormones in a cohort of Egyptian obese Down syndrome children: a comparative study
by: Yahia Sohier, et al.
Published: (2012-10-01) -
Alzheimer Disease in Down Syndrome
by: J Gordon Millichap
Published: (1989-08-01) -
Adiponectin Modulation by Genotype and Maternal Choline Supplementation in a Mouse Model of Down Syndrome and Alzheimer’s Disease
by: Melissa J. Alldred, et al.
Published: (2021-07-01) -
Association of the leptin-to-adiponectin ratio with metabolic syndrome in a sub-Saharan African population
by: Clarisse Noël A. Ayina, et al.
Published: (2017-09-01)